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Method validationAbstract This paper is a continuation to our previous work aiming at development and validation
of a reversed-phase HPLC for modernization of tetracycline-related USP monographs and the USP
general chapter <226>. Previous results showed that the method is accurate and precise for the
assay of tetracycline hydrochloride and the limit of 4-epianhydrotetracycline impurity in the drug
substance and oral suspension monographs. The aim of the current paper is to examine the feasi-
bility of the method for modernization of USP tetracycline hydrochloride capsule monograph.
Speciﬁcity, linearity, accuracy and precision were examined for tetracycline hydrochloride assay
and 4-epianhydrotetracycline limit. The method was linear in the concentration range from 80%
to 160% (r>0.9998) of the assay concentration (0.1 mg/mL) for tetracycline hydrochloride and
from 50% to 150% (r>0.997) of the acceptance criteria speciﬁed in tetracycline hydrochloride cap-
sule monograph for 4-epianhydrotetracycline (NMT 3.0%). The recovery at three concentration
levels for tetracycline hydrochloride assay was between 99% and 101% and the RSD from six prep-
arations at the concentration 0.1 mg/mL is less than 0.6%. The recovery for 4-epianhydrotetracy-
cline limit procedure over the concentration range from 50% to 150% is between 96% and 102%
with RSD less than 5%. The results met the speciﬁed acceptance criteria.
ª 2014 Production and hosting by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.
Open access under CC BY-NC-ND license.1. Introduction
At present, the United State Pharmacopeia (USP) strives to
keep its monographs current with advances in technology.The USP dedicated several monographs for the determination
of tetracycline hydrochloride and 4-epianhydrotetracycline
hydrochloride impurity in different dosage forms using an
HPLC method.1 Some of these monographs refer to the
method outlined in the general chapter <226> for the limit
of 4-epianhydrotetracycline hydrochloride. This method uses
open column technology which is very old and is a target
of modernization by the USP. The HPLC assay method
used in the aforementioned monographs is tedious, uses
undesirable reagent (dimethyl formamide) and, hence, needs
modernization.
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method for simultaneous determination of tetracycline hydro-
chloride and 4-epianhydrotetracycline hydrochloride.2 This
method will replace both the present HPLC method in tetracy-
cline-related monographs and the open column method pre-
scribed in the general chapter <226>, with the intent of
referencing all relevant monographs to the general chapter.
The new method proved speciﬁc, linear, accurate and precise
for the drug substance and oral suspension. The advantage
of this method over other HPLC methods3–13 and other elec-
trophoretic methods14,15 is that it is simple, speciﬁc and uses
advanced instrumentations which are available in all laborato-
ries for routine analysis. Thus, it can be recommended as a
compendium method.
Herein, we examine the feasibility of our previously
reported reversed-phase HPLC method2 for the determination
of tetracycline hydrochloride and the limit of 4-epianhydrotet-
racycline hydrochloride impurity in capsules. The speciﬁcity,
linearity, accuracy and precision of the method for both com-
pounds are adequately discussed. This work aims at moderni-
zation of tetracycline hydrochloride capsule USP monograph.2. Materials and methods
2.1. Materials
Tetracycline hydrochloride (97.6% purity, Lot L1H374), epi-
tetracycline hydrochloride (Lot G0E261), and 4-epianhydro-
tetracycline hydrochloride (Lot K0F299) were USP
Reference Standards (Rockville, MD, USA). Anhydrotetracy-
cline hydrochloride (Lot SZBA299XV) was purchased from
Sigma–Aldrich (Louis, MO, USA). Tetracycline hydrochloride
capsule (250 mg) was obtained from TEVA Pharmaceutical
(Rockville, MD, USA).
All reagents were of analytical grade. Water was obtained
from a Milli-Q water puriﬁcation system (Millipore, Billerica,
MA, USA).
2.2. Chromatographic conditions
The HPLC system was Waters 2695 Alliance systems con-
trolled with Waters Empower 2 software. We followed the
same chromatographic conditions described previously.2 We
used a Phenomenex (Torrance, CA, USA) Prodigy ODS-3,
3 lm, 4.6 · 150 mm column. The column temperature was
set at 50 C. The autosampler temperature was kept at 4 C.
Eluent components were 0.1% H3PO4 and acetonitrile. The
proportion of acetonitrile was varied from 15% to 40% in
7.5 min, back to 15% in 0.1 min, and held at 15% for
2.4 min. The ﬂow rate was 1.0 mL/min. The detection wave-
length was 280 nm. The injection volume was 10 lL.
2.3. Diluent
The diluent was prepared by mixing 2 mL of 85% phosphoric
acid with 2 L of water.
2.4. System suitability solution
We used a system suitability solution containing 25 lg/mL of
each of the following compounds: tetracycline hydrochloride,epitetracycline hydrochloride, 4-epianhydrotetracycline hydro-
chloride, and anhydrotetracycline hydrochloride.2
2.5. Standard solutions
A standard solution of tetracycline hydrochloride (0.1 mg/mL)
was prepared in a 100 mL measuring ﬂask by dissolving an
accurately weighed 10 mg of USP tetracycline hydrochloride
RS in 50 mL diluent and completing the ﬂask to mark with
the diluent. The standard solution for the limit procedure
had a concentration corresponding to that for the limit proce-
dure stated in the USP-relevant monograph. The limit for tet-
racycline hydrochloride capsule monograph is 3.0%, so the
standard solution concentration was 3.0 lg/mL of 4-epianhy-
drotetracycline hydrochloride.
2.6. Validation solutions for the assay procedure
2.6.1. Accuracy stock solution (0.1 mg/mL tetracycline
hydrochloride)
An accurately weighed 20 capsules were emptied into a mortar.
The capsule shells were weighed and the net content was calcu-
lated. The capsule contents were well mixed using a pestle. An
accuracy stock solution was prepared in a 1000 mL volumetric
ﬂask by dissolving an accurately weighed amount of the mixed
powder (equivalent to 100 mg tetracycline HCl) in 500 mL dil-
uent with aid of sonication for 5 min. The ﬂask was then
allowed to cool and completed to volume with the diluent.
2.6.2. Linearity solutions
A 160% solution was prepared by dissolving 6 mg of USP tet-
racycline hydrochloride reference standard in 100.0 mL of the
accuracy stock solution. Four other solutions at the concentra-
tion levels 80%, 96%, 112%, 144%, were prepared from the
160% solution by diluting 5 mL to 10 mL, 6 mL to 10 mL,
7 mL to 10 mL and 9 mL to 10 mL with the diluent.
2.6.3. Accuracy working solutions
The accuracy solutions were prepared at three concentration
levels 120%, 140%and 160%, in triplicate at each level, by spik-
ing the accuracy stock solution with USP tetracycline hydro-
chloride reference standard according to the following scheme:
 120% Level: An accurately weighed 2 mg of USP tetra-
cycline hydrochloride RS was dissolved and diluted to
100.0 mL with the accuracy stock solution.
 140% Level: An accurately weighed 4 mg of USP tetra-
cycline hydrochloride RS was dissolved and diluted to
100.0 mL with the accuracy stock solution.
 160% Level: An accurately weighed 6 mg of USP tetra-
cycline hydrochloride RS was dissolved and diluted to
100.0 mL with the accuracy stock solution.2.6.4. Precision solutions
The precision solution was prepared in a 250 mL volumetric
ﬂask by dissolving an accurately weighed amount of the mixed
powder of capsules equivalent to 25 mg of tetracycline hydro-
chloride in a 100 mL diluent. The solution was sonicated for
5 min. The ﬂask was allowed to cool and completed to mark
with the diluent. Six individual solutions of the same concen-
tration were prepared.
Figure 1 Typical HPLC chromatogram for system suitability
solution containing 25 lg/mL each of tetracycline hydrochloride,
epitetracycline hydrochloride, 4-epianhydrotetracycline hydro-
chloride, and anhydrotetracycline hydrochloride.
HPLC method for determination of tetracycline hydrochloride 2412.7. Validation solutions for the limit procedure
The amount of 4-epianhydrotetracycline hydrochloride impu-
rity in tetracycline hydrochloride capsules was estimated using
our previously published method2 to be 0.12%. This amount
represents 4% of the maximum limit allowed by the USP for
4-epianhydrotetracycline hydrochloride. Therefore it is not
negligible and has been considered during the preparation of
the validation solutions.
2.7.1. Solution A
Sample solution (1.0 mg/mL tetracycline hydrochloride). An
accurately weighed amount of the mixed powder (equivalent
to 100 mg tetracycline HCl) was transferred into a 100.0 mL
volumetric ﬂask and dissolved in 50 mL diluent with aid of
sonication for 5 min. The ﬂask was allowed to cool and then
completed to volume with the diluent.
2.7.2. Solution B
Stock impurity solution. An accurately weighed 7.2 mg of USP
4-epianhydrotetracycline RS, in triplicate, was transferred into
a 100 mL volumetric ﬂask, dissolved in 50 mL of the diluent;
the ﬂask was then completed to mark with the diluent. Three
individual solutions were prepared by diluting 10.0 mL of each
solution to 100 mL with diluent.
2.7.3. Linearity, accuracy and precision solutions
These solutions were prepared, in triplicate, at the concentra-
tion levels 50%, 75%, 100%, 125% and 150% of the concen-
tration 3 lg/mL of 4-epianhydrotetracycline HCl by spiking
the sample solution (solution A) with the stock impurity solu-
tions (solution B) as follows:
 Standard impurity solution: Dilute 10.0 mL of solution B to
25.0 mL with diluent.
 Spike 150%: Dilute 6.0 mL of solution B and 1.0 mL of
solution A to 10.0 mL with diluent.
 Spike 125%: Dilute 5.0 mL of solution B and 1.0 mL of
solution A to 10.0 mL with diluent.
 Spike 100%: Dilute 10.0 mL of solution B and 2.5 mL of
solution A to 25.0 mL with diluent.
 Spike 75%: Dilute 15.0 mL of solution B and 5.0 mL of
solution A to 50.0 mL with diluent.
 Spike 50%: Dilute 10.0 mL of solution B and 5.0 mL of
solution A to 50.0 mL with diluent.
3. Results and discussion
3.1. Method validation
We have developed previously a robust HPLC method for
modernization of tetracycline-related USP monographs.2 In
brief, the method allowed separation of tetracycline hydro-
chloride and its related compounds in less than 8 min using a
gradient mode of HPLC and a mobile phase composed of
0.1% phosphoric acid and acetonitrile. The peaks were well
resolved. Stress studies showed no interference at the retention
time of tetracycline hydrochloride and its related compounds
from the possible degradants. The method was linear, accurateand precise for tetracycline hydrochloride and 4-epianhydro-
tetracycline hydrochloride in the drug substance and oral sus-
pension monographs. Here, we extend the method validation
to the tetracycline hydrochloride capsule USP monograph.
According to USP, system suitability testing is an integral
part of analytical methods to evaluate chromatographic param-
eters of the system.1 Thus, replicate injections of the system suit-
ability solution and resolution solution were made throughout
the validation process. A system suitability chromatogram per-
formed prior to method validation measurements is shown in
Fig. 1. The resolution between epitetracycline hydrochloride
and tetracycline hydrochloride was always greater than 7 in
all system suitability chromatograms, and that between tetracy-
cline hydrochloride and 4-epianhydrotetracycline was greater
than 29. The resolution between 4-epianhydrotetracycline and
anhydrotetracycline was greater than 11. The resolution was
calculated according to theUSP guidelines.1 Tailing for the four
peaks was between 0.9 and 1.2 and the precision for the tetracy-
cline hydrochloride and 4-epianhydrotetracycline hydrochlo-
ride peaks for ﬁve replicate injections was less than 0.5% and
2%, respectively. The retention times were 3.4, 3.9, 6.1 and
7.1 for epitetracycline hydrochloride, tetracycline hydrochlo-
ride, 4-epianhydrotetracycline and anhydrotetracycline, respec-
tively. The results indicate that the system suitability
requirements are passed and, consequently, further chromato-
graphic parameters can be examined.
3.2. Speciﬁcity
USP deﬁnes speciﬁcity as the ability to assess unequivocally
the analyte in the presence of components that may be
expected to be present, such as impurities, degradation prod-
ucts, and matrix components. The speciﬁcity of the HPLC
method was examined by peak identiﬁcation; no interferences
appeared at the retention time of tetracycline hydrochloride
and 4-epianhydotetracycline hydrochloride in the chromato-
gram from sample solution of capsule that contains 0.1 mg/
mL tetracycline hydrochloride (Fig. 2).
3.3. Solution stability
The stability of spiked 100% sample solution was monitored
for 24 h. The peak area change for 4-epianhydrotetracycline
Figure 2 Typical chromatogram for capsule solution contains 0.1 mg/mL tetracycline hydrochloride.
Table 1 Accuracy and precision results for the tetracycline
hydrochloride assay procedure.
Level (%) Spiking conc.
(lg/mL)
Conc. found
(lg/mL)
Recovery (%)
Accuracy
120 22.55 22.34
20.38 19.91 99.6
20.78 21.17
140 38.73 38.76
38.68 39.07 100.5
38.59 38.77
160 57.71 58.07
58.02 58.84 100.8
60.80 60.94
Precision
100 100.69 101.23 100.54
101.58 102.31 100.72
99.81 100.34 100.53
102.84 102.08 99.27
101.96 102.31 100.34
102.40 101.99 99.60
Average = 100.17
%RSD (n = 6) = 0.59
Acceptance criteria. Accuracy: The average recovery at each level is
between 98% and 102%; precision: The RSD of the assay result
from the six preparations is NMT 2.0%.
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increased to about 1.5% after 9 h and 2.5% after 11 h. In con-
trast, the tetracycline hydrochloride peak was stable for 24 h.
The peak area change was less than 0.5%. All subsequent val-
idation measurements were carried out within the time period
where the peak area change was less than 1%.
3.4. Filter study
A 0.22 lm hydrophilic syringe ﬁlter was used for sample solu-
tion of 0.1 mg/mL. The ﬁlter study showed no effect of the ﬁl-
ter on the concentrations of tetracycline hydrochloride and 4-
epianhydrotetracycline hydrochloride.
3.5. Linearity
Linearity was established by least squares regression analysis
of the calibration curve. Calibration curve for the assay
method was obtained over the calibration range from 80%
to 160% of assay concentration (0.1 mg/mL). The correlation
coefﬁcient (r) was greater than 0.9998. The results show that
an excellent correlation exists between the peak area and con-
centration of the analyte. The regression equation is as follows:
y ¼ 188117xþ 80:146 ð1Þ
Linear calibration plots for the 4-epianhydrotetracycline
hydrochloride limit method was obtained for three sets of con-
centrations each cover the concentration range from 50 to
150% of the limit concentration 3 lg/mL. The correlation
coefﬁcients (r) obtained were greater than 0.997. The regres-
sion equations for the three sets were as follows:
y ¼ 39158xþ 9017; r ¼ 0:998 ð2Þ
y ¼ 42625xþ 6214; r ¼ 0:997 ð3Þ
y ¼ 40984xþ 1844; r ¼ 0:999 ð4Þ
The results met the speciﬁed acceptance criteria for the
assay procedure (r is not less than 0.999) and for the limit pro-
cedure (r is not less than 0.99).
3.6. Accuracy and precision of the assay procedure
Instrument precision was determined by replicate injections of
the resolution solutions. The relative standard deviation
(%RSD) for the tetracycline peak response was below 1.0%.
USP precision is deﬁned as the degree of agreement among
individual test results when the method is applied repeatedly
to multiple samplings of a homogenous sample, and accuracy
is, the closeness of test results to the true value.The accuracy of the proposed method was determined by
the standard addition method at three different levels corre-
sponding to 120%, 140%, and 160% of the nominal analytical
concentration of 0.1 mg/mL. The mean recovery data obtained
for each level as well as for all levels combined were within
±2%. The %RSD for six preparations at the concentration
0.1 mg/mL was less than 1.0%. The accuracy and precision
results are summarized in Table 1. The results met the speciﬁed
acceptance criteria.
3.7. Accuracy and precision of the limit procedure
The precision of the instrument was tested by six replicate
injections of standard solution of 4-epianhydrotetracycline
hydrochloride. The relative standard deviation (%RSD) of
the peak area response was <1.5%. The amount of 4-epianhy-
drotetracycline impurity in tetracycline hydrochloride capsules
was estimated to be 0.12%. This amount is not negligible by
the USP and was considered during the preparation of the val-
idation solutions. We constructed calibration lines for three
sets of spiked solutions in the concentration range from 50%
Table 2 Accuracy and precision results for 4-epianhydrotet-
racycline hydrochloride limit procedure.
Level (%) Spiking conc.
(lg/mL)
Conc. found
(lg/mL)
Recoverya
(%)
RSDb
(%)
1st set
50 1.44 1.58
75 2.16 2.36
100 2.88 3.16 97.60 3.5
125 3.60 3.72
150 4.32 4.41
2nd set
50 1.55 1.67
75 2.33 2.43
100 3.10 2.99 96.25% 4.1
125 3.88 3.96
150 4.65 4.63
3rd set
50 1.43 1.54
75 2.14 2.27
100 2.86 2.90 101.71% 2.2
125 3.57 3.71
150 4.28 4.45
Acceptance criteria: the recovery is between 95% and 105%; the
precision (RSD) is NMT 5%.
The results met the speciﬁed acceptance criteria.
a %Recovery is the slope of the regression line.
b %RSD is the standard error of the regression slope.
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nals from the spiking assay into the corresponding recovered
concentrations. In further diagram, we plotted the recovered
concentration against the spiking concentration. By a subse-
quent regression, the ‘‘recovery function’’ was obtained for
each set of measurements.16 The regression equations for the
3 set are as follows:
y ¼ 0:976xþ 0:233; r ¼ 0:998 for the 1st set
y ¼ 0:963xþ 0:151; r ¼ 0:997 for the 2nd set
y ¼ 1:017xþ 0:069; r ¼ 0:999 for the 3rd set
The slope of the regression line expresses the recovery and
the standard error of the regression slope expresses the preci-
sion of the analytical method. The spiking concentration,
recovery and precision results are summarized in Table 2.4. Conclusion
In previous work we proposed an HPLC method for modern-
ization of tetracycline-related USP monographs. The method
was validated for the tetracycline hydrochloride drug sub-
stance and oral suspension. The present work proves that the
method is accurate, precise, speciﬁc, linear, and sensitive for
the assay of tetracycline hydrochloride and the limit of 4-
epianhydrotetracycline hydrochloride in capsule. So far, we
have presented the validation results related to the moderniza-
tion of three tetracycline-related USP monographs. The feasi-
bility of using this procedure for modernization other
tetracycline-related USP monographs is still underway.5. Conﬂict of interest
I certify that there is no conﬂict of interest with any ﬁnancial
organization regarding the material discussed in the
manuscript.
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